Oncology


Get Dexur’s Personalized Hospital Specific Presentation on Quality, Safety, Compliance & Education

No Image

By: Avinash Kumar  May. 01, 2019

Dexur analyzed Medicare claims data based on a 5% sample for the time period of Jan 2016 to June 2018, to understand the prevalence of oncology combination therapies. This methodology checked for relevant J codes of HCPCS code set in the claim files across the patient’s history. If a patient used a base drug, it was then checked to see what other drugs were used on the same patient.

Read more